UCB chooses LabLogic software for Brussels R&D centre

9 October 2007

UCB is the latest pharmaceutical company to invest in software for drug metabolism studies from LabLogic Systems.

The company is introducing the market-leading ADME LIMS Debra and the sample tracking system Stacy at its R&D centre in Braine-l'Alleud, Belgium, which specialises in therapeutic solutions for disorders of the central nervous system. Both packages are currently being validated and are expected to go live early in 2008.

The decision to purchase both products was strongly influenced by the fact that Debra can exchange data not just with LabLogic's own Stacy sample tracking and Laura chromatography data system but also with UCB's existing AIDA Whole Body Autoradiography software from Raytest and Pharsight’s WinNonlin.

At UCB's request, the version of Debra being installed (5.6.4) includes a new graphing tool for easy production of histograms, which are typically used to compare drug concentration levels in biological samples, and the ability to prepare treatments with both labelled and unlabelled compounds pre-formulated as solutions.

In Stacy 2.1.3, LabLogic has added support for Oracle 10; a new 'quick find' feature to search for samples and the facility to dispose of boxes. Users can also see and move Debra batches from within Stacy, and print out a transaction report of what they have just added or moved.

LabLogic systems director Huw Loaring commented: 'This order disproves the notion that only the very biggest companies can benefit from the products that we offer; in fact several groups outside the World’s Top 20 pharma are now users of Debra.'